Back

Impact of atrial fibrillation burden on early mitral valve remodeling in patients without significant mitral regurgitation

11 December 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: New imaging insights into valvular heart disease Imaging of Arrhythmias EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Mahmoud Neseem Abdelkawy Shaaban

Aswan Heart Centre, Aswan (Egypt)

5 More presentations in this session

Presentation thumbnail
Increased mitral valve fibroblast activation following myocardial infarction
Doctor A. Barton (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Reclassification from severe to moderate aortic stenosis using hybrid-AVA technique in TAVR patients
Doctor F. Mohacsi (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Can low-gradient aortic stenosis be predicted using a mathematic model? Integration of data from echocardiography, cardiac catheterization and cardiac magnetic resonance
Doctor M. Pu (New York, US)
Abstract Slides Video
Presentation thumbnail
Multimodality approach to low-flow, low-gradient aortic stenosis: sex-specific ct calcium thresholds validated by dobutamine stress echocardiography
Doctor R. Horita (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Is the dominant E wave of the tricuspid inflow a reliable marker for severe tricuspid reguargitation?
Doctor Y. Kawada (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New imaging insights into valvular heart disease
Video

The Event

Event poster

EACVI 2025

11 December - 13 December 2025
You may be interested in
thumbnail
Congress Presentation
Significance of mitral annulus apparatus morphometry in patients with persistent atrial fibrillation
thumbnail
Congress Presentation
The effect of short-term mitral valve regurgitation on atrial remodelling and atrial fibrillation inducibility in an experimental porcine model
thumbnail
Congress Presentation
Catheter ablation of concomitant atrial fibrillation should be performed on all patients planned for interventional mitral valve repair: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources